RE: Oh no !10 Dec 2024 11:35
My point is, noone from the US buys on OTC. it's just rampy talk that pushes the sp. not that i mind as i'd be happy to take advantage of 'blow the bluddy doors off' posts here that encouraged over buying but, as i said, noone in the US ever buys OTC. now, if they listed on US platforms like Semnet, that's a different matter. in fact, it'd be worth considering buying into Semnet at some point, as long as the IPO price isn't an overshoot on the start price. too many IPO's over inflate the value on the launch. but, being financial...